LIVESTOCK: Strong beef prices lift U.S.. live cattle futures

Chicago Mercantile Exchange live cattle on Tuesday gained for a third straight session, helped by recent wholesale beef price advances that may contribute to record-high cash prices this week, traders said. Consumer demand for select beef cuts, which includes roasts, tends to improve during the fall as interest in outdoor grilling wanes. And wholesalers actively



U.S. live cattle futures draw cash price support

Chicago Mercantile Exchange live cattle futures on Friday gained in quiet trading, partly supported by this week’s higher cash prices, traders said. And investors bought CME live cattle with the view that Thursday’s technical-related market selloff was overdone. “The market was extremely quiet with people not knowing which direction to go after yesterday’s wild downward

U.S. live cattle futures slump as funds sell

Chicago Mercantile Exchange live cattle futures finished lower on Thursday as fund liquidation erased early-session cash-infused gains, traders said. Wednesday’s CME live cattle advances, driven by higher cash cattle prices and the firm beef cutout, carried over into Thursday morning’s trade. However, traders took profits in anticipation of cash cattle prices peaking soon as packers





U.S. live cattle hit seven-month high as beef prices gain

Chicago Mercantile Exchange live cattle on Monday climbed to a seven-month high, supported by firm wholesale beef values, traders and analysts said. Friday’s higher-than-expected cash cattle prices motivated futures buyers on Monday. And speculators bought deferred trading months in anticipation of tighter cattle numbers in the months ahead. Thousands of cattle lost to the freak




South Korea suspends some U.S. beef imports over feed additive

South Korea has suspended some U.S. beef imports after detecting the cattle feed additive zilpaterol in meat supplied by a unit of JBS USA, raising concerns that the controversial animal growth enhancer may still be in the supply chain weeks after its manufacturer Merck halted sales of Zilmax, the top-selling zilpaterol-based drug. The South Korean